- Eleven patients enrolled overall in trial to date, with enrollment progressing faster than anticipated - - Monotherapy arm has…
Mr. Glover will also serve as a judge in BioPitch competition for life science companies seeking seed and early-stage investment.ZyVersa…
Vinergy Developing and Investing in the Next Generation of A.I. Driven Health CareAn Emerging Markets Sponsored Commentary ORLANDO, Fla, Sept.…
LOUISVILLE, Ky., Sept. 27, 2023 (GLOBE NEWSWIRE) -- via IBN - CSurgeries, a top-tier online surgical video journal, is proud…
Committed to progressing scalable AI technologies, Augmedix’s newest fully automated product is adaptable to serve acute and ambulatory care settingsSAN…
AUDUBON, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced…
BEDMINSTER, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Matinas BioPharma (NYSE American: MTNB), a clinical-stage biopharmaceutical company focused on redefining…
Scottsdale, Arizona--(Newsfile Corp. - September 27, 2023) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the…
InStatin & InVixa Are Developing Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)Toronto, Ontario--(Newsfile Corp. - September…
Patient enrollment starting in Q4 2023 for proof-of-concept P2a study of CB1 agonist Phase 1 study complete and data will…